Educational information only — not a diagnosis or treatment recommendation.
Content last checked: Jul 15, 2026·Sources & review
Lung cancer is our first complete cancer decision journey. Any stage — newly diagnosed, comparing options, second opinion, or care center expertise. Pick where you are; leave knowing your next step.
Your decision map · about 3 minutes
This is a navigation map, not a reading list. Find your situation, open one guide, and return when the next question comes up.
Before the 6 situations
Short knowledge guides — open one if you still need the basics before picking a decision situation below.
Still figuring out what comes first after a new diagnosis.
Also related
Diagnosed with Stage IV / advanced lung cancerComparing paths, surgery, or a clinical trial.
Want more confidence, another review, different expertise, or care elsewhere.
Advanced disease, brain metastases, recurrence, or a plan that stopped working.
Daily life, burden, travel, time, and whether the plan is workable — start with Quality of Life, Care Team, or Practical Fit.
Also related
Need to compare treatment optionsMonitoring, symptoms to report, and life after cancer.
Also related
Considering a second opinionOn the decision map
Your current decision and the nearest next steps — not the full graph.
Before
Stage IV decision
Facing choices in advanced disease — clarify goals, compare options, and decide what information or expertise would help next.
Open this guide →You are here
Brain metastases
When lung cancer is found in the brain — clarify the findings, compare local and systemic options with disease elsewhere, and prepare the next conversation.
Open this guide →Next
Stage IV decision
Facing choices in advanced disease — clarify goals, compare options, and decide what information or expertise would help next.
Open this guide →Need every node? View the full technical map
Lung cancer decision pathways often involve staging clarity, biomarker testing, surgery versus systemic therapy, and when a second opinion may change the plan. This center organizes common decision questions, treatment comparisons, global care options, and patient decision journeys.
Understanding lung cancer types
Orient to NSCLC vs SCLC, what to find on your pathology report, and how type changes the next conversation.
Open Understanding Types →Understanding lung cancer stage
Orient to what stage means, early vs advanced discussions, and questions to ask before choosing a path.
Open Understanding Stage →Treatment Landscape
Orient to local vs systemic directions, how doctors choose, and which Decision Path to open next — not a treatment menu.
Open Treatment Landscape →Cross-border care is a branch of the journey when a specific capability is missing locally — not a default destination.
Editorial examples of how patients compare options — not verified personal testimonials.
Complete node graph for structure and deep links — most people can stay with the situation map and nearby decisions above.
Diagnosis confirmed
Confirm what is known, which tests are outstanding, and which decisions are time-sensitive. From here the path forks.
Why this matters: This matters because early sequencing mistakes are hard to undo — you need to know which tests change the first plan.
Decision questions
Illustrative journey
Decision fork — paths can run in parallel
Biomarker testing
Make sure pathology and molecular testing are complete enough to shape first-line choices — or decide when waiting is not safe.
Why this matters: This matters because some results may change which treatments are considered first.
Decision questions
Illustrative journey
Branches to
Treatment comparison
Weigh surgery-led versus systemic-led sequencing using stage, markers, and priorities. This is a super-node — major modalities sit under this decision center.
Why this matters: This matters because surgery-led and systemic paths can both be reasonable — the trade-offs are personal and clinical.
Decision center facets
Decision questions
Illustrative journey
Second opinion
Decide whether a pathology, staging, or sequencing review would reduce uncertainty before irreversible steps.
Why this matters: This matters before irreversible steps — another review can confirm pathology, staging, or sequencing.
Decision questions
Illustrative journey
Care center & expertise
Decide whether another center, specialist team, or additional expertise may improve your decision — without ranking hospitals.
Why this matters: The goal is the right expertise for your decision, not simply a more famous center.
Decision questions
Illustrative journey
Stage IV decision
Facing choices in advanced disease — clarify goals, compare options, and decide what information or expertise would help next.
Why this matters: Advanced disease decisions are about goals and trade-offs, not encyclopedia lists of every drug.
Decision questions
Brain metastases
When lung cancer is found in the brain — clarify the findings, compare local and systemic options with disease elsewhere, and prepare the next conversation.
Why this matters: Brain metastases create high fear and fragmented specialty advice; patients need a decision path that holds brain findings and whole-body options together.
Decision questions
Clinical trial decision
Decide whether a clinical trial should be part of your discussion — compared with other options, not as a last resort.
Why this matters: Trials are a decision option at multiple points in the journey — evaluate purpose, evidence, risks, and fit.
Decision questions
Recurrence decision
Reassess what changed, update information, and compare next options — recurrence is a new decision point, not a return to the old plan.
Why this matters: Recurrence decisions carry high pressure; patients need a re-entry path into comparison, information, and second opinion.
Decision questions
Treatment progression
When current treatment is no longer achieving its goal — reassess what changed, update information, and compare the next options.
Why this matters: Treatment change is a new decision point, not the end of the journey — patients need a clear re-entry into comparison and information.
Decision questions
International option
Only explore cross-border care when a specific capability, trial, or specialty review is missing locally.
Why this matters: This matters only when a specific capability is missing locally — not as a default upgrade.
Decision questions
Illustrative journey
Branches to
Surgery decision
Decide whether surgery should be part of your treatment plan — compared with alternatives, not as an automatic best choice.
Why this matters: Surgery is a treatment option, not the decision itself — patients need a comparison frame before a major procedure.
Decision questions
Illustrative journey
Personal goals
Bring personal goals, daily life, and priorities into treatment conversations — quality of life guides decisions, it does not automatically mean less treatment.
Why this matters: Cancer decisions are about your life, not only your cancer — priorities make trade-offs clearer.
Decision questions
Practical fit
Pointer into Care Team, Treatment Options, and Quality of Life — whether a plan can work with cost, travel, time, and support.
Why this matters: Practical factors belong in the conversation. Open the matching decision page rather than treating logistics as a separate encyclopedia.
Decision questions
Illustrative journey
Follow-up monitoring
After active treatment, clarify what to monitor, when to contact the team, and how to rebuild confidence in daily life.
Why this matters: The end of treatment is not the end of care — patients need a clear plan for scans, symptoms, and life after cancer.
Decision questions